Alexandre Demoule to Immunocompromised Host
This is a "connection" page, showing publications Alexandre Demoule has written about Immunocompromised Host.
Connection Strength
0.681
-
Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical Trial. JAMA. 2018 11 27; 320(20):2099-2107.
Score: 0.230
-
High-flow nasal oxygen vs. standard oxygen therapy in immunocompromised patients with acute respiratory failure: study protocol for a randomized controlled trial. Trials. 2018 Mar 05; 19(1):157.
Score: 0.218
-
Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopy. Eur Respir J. 2019 07; 54(1).
Score: 0.060
-
High-Flow Oxygen Therapy for Respiratory Failure in Immunocompromised Patients-Reply. JAMA. 2019 05 14; 321(18):1827.
Score: 0.059
-
Acute respiratory failure in immunocompromised adults. Lancet Respir Med. 2019 02; 7(2):173-186.
Score: 0.058
-
The challenge of avoiding intubation in immunocompromised patients with acute respiratory failure. Expert Rev Respir Med. 2018 10; 12(10):867-880.
Score: 0.056